Author:
Yoshida Daizo,Teramoto Akira
Abstract
The role of angiogenesis in pituitary tumor development used to be questioned, since pituitary tumors have been usually found to be less vascularized than the normal pituitary tissue. Nevertheless, a significantly higher degree of vasculature has been shown in invasive or macropituitary prolactinomas when compared to noninvasive and microprolactinomas. We should know VEGF was found firstly in pituitary anterior lobe, then tumor angiogenesis must occur. Meanwhile the vascular arrangement raised by VEGF is irregular, that sometimes lead to pituitary apoplexy. In this chapter, hypoxia inducible factors (HIF), transcription factors regulating expression of several genes related to oxygen homeostasis are in response to hypoxic stress. We focus on tumor angiogenesis regulated by the signaling cascade in tumor angiogenesis in pituitary tumor.
Reference33 articles.
1. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Molecular Pharmacology. 2006;70(5):1469-1480
2. Fallah J, Rini BI. HIF inhibitors: Status of current clinical development. Current Oncology Reports. Jan 22 2019;21(1):6
3. Albadari N, Deng S, Li W. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opinion on Drug Discovery. Jul 2019;14(7):667-682
4. Graham K, Unger E. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. International Journal of Nanomedicine. Oct 2018;13:6049-6058
5. Hsu TS, Lin YL, Wang YA, Mo ST, Chi PY, Lai AC, et al. HIF-2α is indispensable for regulatory T cell function. Nature Communications. Oct 6 2020;11(1):5005. doi: 10.1038/s41467-020-18731-y